Trial Profile
Long-Term Comparison of Everolimus-Eluting and Biolimus-Eluting Stents in All-Comer Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Everolimus
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms EverBio
- 18 Nov 2011 New trial record